Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Harvard Business School
Boehringer Ingelheim
McKinsey
QuintilesIMS
Chubb
Daiichi Sankyo
Merck

Generated: September 25, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Livostin

« Back to Dashboard

Bulk Pharmaceutical API Sources for Livostin

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ➤ Sign Up 54385 ➤ Sign Up
ABI Chem ➤ Sign Up AC1L1GWR ➤ Sign Up
ChemMol ➤ Sign Up 49401013 ➤ Sign Up
Chembase.cn ➤ Sign Up 977 ➤ Sign Up
AKos Consulting & Solutions ➤ Sign Up AKOS016013998 ➤ Sign Up
A&J Pharmtech CO., LTD. ➤ Sign Up AJ-23611 ➤ Sign Up
AN PharmaTech ➤ Sign Up AN-6364 ➤ Sign Up
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Accenture
Boehringer Ingelheim
Healthtrust
Cipla
US Department of Justice
Citi
UBS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.